Obstacles to cardiovascular prevention in general practice

Objective.— In spite of a wide diffusion of the European guidelines for prevention of cardiovascular (CV) diseases, failures in both primary and secondary CV prevention are currently acknowledged. We wanted to uncover obstacles to CV prevention related to the general practitioner’s (GP) knowledge and attitudes. Methods and results.— A postal questionnaire was sent to a random sample of GPs from two Belgian provinces. 282 GPs (32%) answered the questionnaire.The proportion of adequate answers was calculated for each item. The main obstacles related to three domains. Regarding awareness of CV burden, 83% of the GPs underestimated the lethality of myocardial infarction and 41% underestimated the prevalence of high CV risk in the adult population. Regarding CV risk assessment, 80% thought that total cholesterol (TC) adequately reflected the individual CV risk; only 55% systematically registered the patient’s CV risk factors in the medical record. A tool for global CV risk assessment was never used by 53% of the GPs. Regarding CV therapeutic attitudes, 66% systematically prescribed a lipid-lowering drug to patients with high TC while 62% did not take into account the evidence-based therapeutic targets in type 2 diabetic patients. Conclusions.— This survey showed that these GPs underestimated the CV burden, lacked a systematic approach to global risk assessment and used to focus on cholesterol treatment rather than on global CV risk management.

[1]  P. F. Kauff Group , 2000, Elegant Design.

[2]  J. Shepherd Economics of lipid lowering in primary prevention: lessons from the West of Scotland Coronary Prevention Study. , 2001, The American journal of cardiology.

[3]  A. Folsom,et al.  Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.

[4]  Chris Todd,et al.  Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs. , 2002, Family practice.

[5]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[6]  M. Abrahamowicz,et al.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.

[7]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .

[8]  G. Breithardt,et al.  Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. , 2000, European heart journal.

[9]  David R. Wood,et al.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.

[10]  J. Knottnerus,et al.  Barriers to working according to cholesterol guidelines. A randomized controlled trial on implementation of national guidelines in 20 general practices , 1998 .

[11]  G. Backer,et al.  LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals , 2000 .

[12]  G. Assmann,et al.  The Münster Heart Study (PROCAM). Results of follow-up at 8 years. , 1998, European heart journal.

[13]  S. Marriott,et al.  Using Clinical Guidelines , 1998 .

[14]  W. Rosenberg,et al.  Evidence based medicine: an approach to clinical problem-solving , 1995, BMJ.

[15]  Philippe Amouyel,et al.  A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. , 1997 .

[16]  D. Wood,et al.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.

[17]  D. De Bacquer,et al.  Trends in coronary heart disease in two Belgian areas: results from the MONICA Ghent-Charleroi Study. , 1999, Journal of epidemiology and community health.

[18]  J. Knottnerus,et al.  Comparison of appropriateness of cholesterol testing in general practice with the recommendations of national guidelines: an audit of patient records in 20 general practices. , 1996, Quality in health care : QHC.

[19]  H. Blackburn,et al.  Primary prevention of coronary heart disease. , 1987, Circulation.

[20]  Jeremy M. Grimshaw,et al.  Using clinical guidelines , 1999 .

[21]  T. Lancet,et al.  West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996, The Lancet.